Title:
TREATMENT OF TUMOR METASTASES AND CANCER
Document Type and Number:
Japanese Patent JP2015163628
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a cancer treatment agent for inhibiting tumor metastases.SOLUTION: Tumor metastases are inhibited by administration of a combined therapeutic agent including effective amounts of Interleukin-2 and a methylol transfer agent such as taurolidine, taurultam or mixtures thereof.
Inventors:
REDMOND H PAUL
PFIRRMANN ROLF W
PFIRRMANN ROLF W
Application Number:
JP2015093930A
Publication Date:
September 10, 2015
Filing Date:
May 01, 2015
Export Citation:
Assignee:
GEISTLICH SOEHNE AG
International Classes:
A61K31/549; A61K45/00; A61K38/00; A61K38/20; A61P35/00; A61P35/02; A61P35/04; A61P43/00
Domestic Patent References:
| JP2002332241A | 2002-11-22 | |||
| JPH05500973A | 1993-02-25 |
Other References:
LEGHA SS, ET AL.: "Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma", CANCER, vol. 77, no. 1, JPN6016013227, 1 January 1996 (1996-01-01), pages 89 - 96
Attorney, Agent or Firm:
Michiharu Soga
Kajinami order
Kazuhiro Oyaku
Kajinami order
Kazuhiro Oyaku
Previous Patent: T-CELL DEATH-INDUCING EPITOPES
Next Patent: DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS
Next Patent: DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS